Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for TEMOZOLOMIDE

Ingredient

TEMOZOLOMIDE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TEVA-TEMOZOLOMIDE	250MG	CAPSULE	Resolved	2023-01-19	2023-04-28	181628
TEVA-TEMOZOLOMIDE	250MG	CAPSULE	Resolved	2022-01-20	2022-03-09	153135
TEVA-TEMOZOLOMIDE	20MG	CAPSULE	Resolved	2023-10-19	2025-08-08	207542
TEVA-TEMOZOLOMIDE	100MG	CAPSULE	Resolved	2022-03-04	2022-03-09	156061
TEVA-TEMOZOLOMIDE	100MG	CAPSULE	Resolved	2023-08-17	2025-08-08	202295
TEVA-TEMOZOLOMIDE	140MG	CAPSULE	Resolved	2024-01-11	2026-01-07	215734

Previous
1
…
7
8
9

Showing 81 to 86 of 86

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TARO-TEMOZOLOMIDE	5MG	CAPSULE	Discontinued	2020-08-28	2020-08-28	123252
TARO-TEMOZOLOMIDE	20MG	CAPSULE	Discontinued	2020-08-28	2020-08-28	123255
TARO-TEMOZOLOMIDE	100MG	CAPSULE	Discontinued	2020-08-28	2020-08-28	123258
TEVA-TEMOZOLOMIDE	20MG	CAPSULE	Discontinued	2025-05-28	2025-05-28	258609
TEVA-TEMOZOLOMIDE	100MG	CAPSULE	Discontinued	2025-05-28	2025-05-28	258603

1

Showing 1 to 5 of 5